Tau bears a caspase 3-consensus site and the caspase-cleaved form of Tau as well as cleaved (active) caspase 9 are detected with specific antibodies in neurons from AD patients but not non-AD controls (Rohn et al., 2002; Gamblin et al., 2003). This evidence concerns the gene MAPT and Alzheimer disease.